[go: up one dir, main page]

ZA200603543B - Use of desoxypeganine for the treatment of schizophrenic psychoses - Google Patents

Use of desoxypeganine for the treatment of schizophrenic psychoses

Info

Publication number
ZA200603543B
ZA200603543B ZA200603543A ZA200603543A ZA200603543B ZA 200603543 B ZA200603543 B ZA 200603543B ZA 200603543 A ZA200603543 A ZA 200603543A ZA 200603543 A ZA200603543 A ZA 200603543A ZA 200603543 B ZA200603543 B ZA 200603543B
Authority
ZA
South Africa
Prior art keywords
desoxypeganine
treatment
schizophrenic psychoses
schizophrenic
psychoses
Prior art date
Application number
ZA200603543A
Other languages
English (en)
Inventor
Moormann Joachim
Opitz Klaus
Winterhoff Hilke
Original Assignee
Hf Arzneimettelforschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34625212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200603543(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimettelforschung Gmbh filed Critical Hf Arzneimettelforschung Gmbh
Publication of ZA200603543B publication Critical patent/ZA200603543B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200603543A 2003-11-24 2006-05-05 Use of desoxypeganine for the treatment of schizophrenic psychoses ZA200603543B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10354893A DE10354893B4 (de) 2003-11-24 2003-11-24 Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen

Publications (1)

Publication Number Publication Date
ZA200603543B true ZA200603543B (en) 2007-03-28

Family

ID=34625212

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200603543A ZA200603543B (en) 2003-11-24 2006-05-05 Use of desoxypeganine for the treatment of schizophrenic psychoses

Country Status (23)

Country Link
US (1) US20070072947A1 (xx)
EP (1) EP1725229B1 (xx)
JP (1) JP2007512269A (xx)
KR (1) KR20070085036A (xx)
CN (1) CN1886127A (xx)
AR (1) AR046664A1 (xx)
AT (1) ATE424197T1 (xx)
AU (1) AU2004294689B2 (xx)
BR (1) BRPI0416411A (xx)
CA (1) CA2547171A1 (xx)
DE (2) DE10354893B4 (xx)
DK (1) DK1725229T3 (xx)
EA (1) EA012033B1 (xx)
ES (1) ES2323645T3 (xx)
IL (1) IL175772A0 (xx)
MY (1) MY141730A (xx)
NO (1) NO20062666L (xx)
NZ (1) NZ547103A (xx)
SI (1) SI1725229T1 (xx)
TW (1) TW200607507A (xx)
UA (1) UA86951C2 (xx)
WO (1) WO2005053673A1 (xx)
ZA (1) ZA200603543B (xx)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression

Also Published As

Publication number Publication date
AU2004294689B2 (en) 2010-01-07
DK1725229T3 (da) 2009-06-22
EA012033B1 (ru) 2009-06-30
MY141730A (en) 2010-06-15
JP2007512269A (ja) 2007-05-17
ES2323645T3 (es) 2009-07-22
BRPI0416411A (pt) 2007-01-09
US20070072947A1 (en) 2007-03-29
UA86951C2 (ru) 2009-06-10
EP1725229B1 (de) 2009-03-04
NZ547103A (en) 2009-07-31
CN1886127A (zh) 2006-12-27
ATE424197T1 (de) 2009-03-15
KR20070085036A (ko) 2007-08-27
TW200607507A (en) 2006-03-01
DE10354893A1 (de) 2005-06-30
EA200601016A1 (ru) 2006-10-27
DE502004009105D1 (de) 2009-04-16
IL175772A0 (en) 2008-04-13
NO20062666L (no) 2006-06-09
WO2005053673A1 (de) 2005-06-16
HK1093696A1 (zh) 2007-03-09
DE10354893B4 (de) 2011-03-10
AU2004294689A1 (en) 2005-06-16
CA2547171A1 (en) 2005-06-16
AR046664A1 (es) 2005-12-14
SI1725229T1 (sl) 2009-08-31
EP1725229A1 (de) 2006-11-29

Similar Documents

Publication Publication Date Title
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
IL174075A0 (en) 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
IL174014A0 (en) Methods for the treatment of endometriosis
GB0329874D0 (en) Compounds useful for the treatment of diseases
AP2005003336A0 (en) Combination for the treatment of ADHD
GB0305150D0 (en) Use of therapeutic compounds
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
IL174927A0 (en) Use of organic compounds
GB0303615D0 (en) Use of organic compounds
ZA200603543B (en) Use of desoxypeganine for the treatment of schizophrenic psychoses
ZA200600494B (en) Reduction of the concentration of undesired compounds
GB0327975D0 (en) Methods of treatment
ZA200606780B (en) Compounds for the treatment of diseases
GB0303613D0 (en) Use of organic compounds
GB0425064D0 (en) Compounds useful for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0301841D0 (en) Use of chemical compounds for the treatment of functional dyspepsia
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
GB0313801D0 (en) Novel methods of treatment
GB0307281D0 (en) Use of organic compounds
GB0302091D0 (en) Use of organic compounds